Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.480
-0.140 (-5.34%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $2.57 million as of April 25, 2025. Its market cap has decreased by -41.51% in one year.
Market Cap
2.57M
Enterprise Value
41.47M
1-Year Change
-41.51%
Ranking
Category
Stock Price
$2.48
Market Cap Chart
Since October 12, 2017, Venus Concept's market cap has decreased from $278.20M to $2.57M, a decrease of -99.07%. That is a compound annual growth rate of -46.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 1.90M | -29.63% |
| Dec 31, 2024 | 2.70M | -58.46% |
| Dec 29, 2023 | 6.50M | -69.91% |
| Dec 30, 2022 | 21.60M | -76.55% |
| Dec 31, 2021 | 92.10M | 29.35% |
| Dec 31, 2020 | 71.20M | -48.92% |
| Dec 31, 2019 | 139.40M | 687.57% |
| Dec 31, 2018 | 17.70M | -86.70% |
| Dec 29, 2017 | 133.10M | -52.16% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 789.68B |
| UnitedHealth Group | 379.60B |
| Johnson & Johnson | 369.74B |
| AbbVie | 330.76B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.91B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |